Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lilly CEO Calls for a 'Wave of Invention' to Reduce the Toll of Diabetes
Yahoo
Wednesday, November 3, 2010 - 10:49am
tags:
Pharma CEOs, Eli Lilly, diabetes, John Lechleiter
Grifols Slumps on The Deal Report That U.S. May Seek to Block Talecris Buy
Bloomberg
Wednesday, November 3, 2010 - 10:47am
tags:
Grifols, Talecris, M&A
Drugmakers, Whistleblowers And The SEC
Pharmalot
Wednesday, November 3, 2010 - 10:46am
tags:
whistleblowers, SEC
Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound
Yahoo
Wednesday, November 3, 2010 - 10:44am
tags:
Simcere, Bristol-Myers Squibb, China, oncology, cancer
Pharma layoffs drop to 1,929 in October
Fierce Pharma
Wednesday, November 3, 2010 - 8:18am
tags:
layoffs
Novartis's Onbrez better than Pfizer drug in COPD
Reuters
Wednesday, November 3, 2010 - 8:17am
tags:
Novartis, Onbrez, Pfizer, COPD
Biogen laying off 13 percent of its work force
Yahoo/AP
Wednesday, November 3, 2010 - 7:53am
tags:
Biogen Idec, layoffs
Lilly Announces China R&D Center in Major Strategic Departure
Seeking Alpha
Wednesday, November 3, 2010 - 7:48am
tags:
Eli Lilly, China, R&D
Time to Sell Amgen?
Motley Fool
Wednesday, November 3, 2010 - 6:57am
tags:
Amgen
Cadence's Ofirmev Is Approved by U.S. FDA for Treatment of Pain, Fevers
Bloomberg
Wednesday, November 3, 2010 - 6:55am
tags:
Ofirmev, FDA, Cadence Pharmaceuticals, acetaminophen
Forest settles antidepressant liability suits
Fierce Pharma
Tuesday, November 2, 2010 - 7:34pm
tags:
lawsuits, Forest Labs, antidepressants, Celexa, Lexapro
FDA extends review of Bristol-Myers melanoma drug
Yahoo/AP
Tuesday, November 2, 2010 - 7:33pm
tags:
FDA, melanoma, Bristol-Myers Squibb, ipilimumab
The Bottom Line on Why Pfizer Bought Wyeth
WSJ Online
Tuesday, November 2, 2010 - 6:37pm
tags:
Pfizer, M&A, Wyeth
Can You Trust the Cash Flow at GlaxoSmithKline?
Motley Fool
Tuesday, November 2, 2010 - 6:14pm
tags:
GSK
Abbott Challenges $1.67 Billion Patent Loss to J&J Over Arthritis Therapy
Bloomberg
Tuesday, November 2, 2010 - 6:12pm
tags:
Abbott Laboratories, patents, Humira, J&A, arthritis
Amgen proposes key hurdles for biosimilar regs
Fierce Biotech
Tuesday, November 2, 2010 - 11:27am
tags:
Amgen, biosimilars
Pharma wants selective tweaks to healthcare reform
Fierce Pharma
Tuesday, November 2, 2010 - 11:18am
tags:
healthcare reform
Dynavax closes $42M stock sale
Bizjournals.com
Tuesday, November 2, 2010 - 11:16am
tags:
Dynavax, stock offering
Will Avanir Continue to Trend Higher?
Seeking Alpha
Tuesday, November 2, 2010 - 11:14am
tags:
Avanir
Teva 3Q net income jumps 62 percent on sales
Yahoo/AP
Tuesday, November 2, 2010 - 11:13am
tags:
Teva Pharmaceuticals, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.